Winklevoss Capital Fund, LLC 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-16 8:25 pm Purchase | 2025-10-08 | 13D | Leap Therapeutics, Inc. LPTX | Winklevoss Capital Fund, LLC | 12,084,463 19.900% | 12,084,463 (New Position) | Filing |